It demonstrated activity in animal models of stroke, but human trials demonstrated no effect on mortality or other outcomes in subarachnoid haemorrhage and worsened results in ischemic stroke.
It demonstrated activity in animal models of stroke. Human trials demonstrated no effect on mortality or other outcomes in subarachnoid haemorrhage. Human trials worsened results in ischemic stroke.